From: Baseline and interim [18F]FDG-PET/MRI to assess treatment response and survival in patients with M0 esophageal squamous cell carcinoma treated by curative-intent therapy
OS
PFS
c-index
95% CI
TNM stage
0.56
0.49–0.62
0.53
0.45–0.61
PET/MRI model for OS
0.79*
0.66–0.91
PET/MRI model for PFS
0.70**
0.60–0.80